Robert Renton

626 total citations
7 papers, 442 citations indexed

About

Robert Renton is a scholar working on Pharmacology, Immunology and Allergy and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert Renton has authored 7 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Immunology and Allergy and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert Renton's work include Allergic Rhinitis and Sensitization (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Respiratory and Cough-Related Research (2 papers). Robert Renton is often cited by papers focused on Allergic Rhinitis and Sensitization (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Respiratory and Cough-Related Research (2 papers). Robert Renton collaborates with scholars based in United Kingdom. Robert Renton's co-authors include M L Burr, P M Sweetnam, Samantha Hughes, P C Elwood, Alexandra Cochrane, Ellana Welsby, Carrie Fidler, A. J. CUMMINGS, B. K. MARTIN and C. I. Backhouse and has published in prestigious journals such as Postgraduate Medical Journal, International Journal of Clinical Practice and Journal of International Medical Research.

In The Last Decade

Robert Renton

7 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Renton United Kingdom 6 259 121 84 55 54 7 442
John R. Luderer United States 10 154 0.6× 69 0.6× 50 0.6× 16 0.3× 40 0.7× 16 380
B. H. Ch. Stricker Netherlands 10 194 0.7× 100 0.8× 70 0.8× 23 0.4× 42 0.8× 16 551
D E Jewitt United Kingdom 10 348 1.3× 53 0.4× 139 1.7× 110 2.0× 21 0.4× 14 493
Antonella Piccinelli Italy 9 151 0.6× 65 0.5× 48 0.6× 8 0.1× 76 1.4× 11 583
Christopher J. Needs Australia 9 55 0.2× 100 0.8× 52 0.6× 12 0.2× 26 0.5× 13 484
Çağdaş Akgüllü Türkiye 14 123 0.5× 23 0.2× 65 0.8× 38 0.7× 27 0.5× 42 358
Christopher N. Floyd United Kingdom 13 329 1.3× 80 0.7× 87 1.0× 91 1.7× 19 0.4× 30 505
Gabriella Pecci Italy 6 66 0.3× 187 1.5× 34 0.4× 13 0.2× 40 0.7× 8 453
Marcia Poland United States 15 287 1.1× 199 1.6× 183 2.2× 5 0.1× 61 1.1× 33 698
Virginia M. Haver United States 11 54 0.2× 51 0.4× 23 0.3× 29 0.5× 25 0.5× 20 383

Countries citing papers authored by Robert Renton

Since Specialization
Citations

This map shows the geographic impact of Robert Renton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Renton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Renton more than expected).

Fields of papers citing papers by Robert Renton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Renton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Renton. The network helps show where Robert Renton may publish in the future.

Co-authorship network of co-authors of Robert Renton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Renton. A scholar is included among the top collaborators of Robert Renton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Renton. Robert Renton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Renton, Robert, et al.. (1991). Multicenter, crossover study of the efficacy and tolerability of terfenadine, 120 mg, versus cetirizine, 10 mg, in perennial allergic rhinitis.. PubMed. 67(4). 416–20. 20 indexed citations
2.
Backhouse, C. I., et al.. (1990). Multicentre, double‐blind comparison of terfenadine and cetirizine in patients with seasonal allergic rhinitis. International Journal of Clinical Practice. 44(3). 88–91. 22 indexed citations
3.
Brantingham, Patricia L., et al.. (1989). A comparison of alprazolam with amitriptyline in the treatment of patients with neurotic or reactive depression. Irish Journal of Medical Science (1971 -). 158(5). 110–113. 9 indexed citations
4.
Renton, Robert, et al.. (1984). Comparative Trial of Two Dose Regimens of Terfenadine in Patients with Hay Fever. Journal of International Medical Research. 12(6). 333–337. 16 indexed citations
5.
Rowan, R. M., Robert Renton, G. A. McDonald, S. J. CORNE, & Daniel F. Brown. (1976). Inhibition of platelet release reaction by acetylsalicylic acid. Postgraduate Medical Journal. 52(604). 71–75. 4 indexed citations
6.
Elwood, P C, Alexandra Cochrane, M L Burr, et al.. (1974). A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction. BMJ. 1(5905). 436–440. 348 indexed citations
7.
CUMMINGS, A. J., B. K. MARTIN, & Robert Renton. (1966). THE ELIMINATION OF SALICYLIC ACID IN MAN: SERUM CONCENTRATIONS AND URINARY EXCRETION RATES. British Journal of Pharmacology and Chemotherapy. 26(2). 461–467. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026